The HST6 antibody likely refers to monoclonal antibodies (e.g., OKT6, Leu-6, or C56) targeting the human T6 antigen, a heterodimeric glycoprotein expressed on thymocytes and Langerhans cells. The T6 antigen consists of:
A 48 kDa heavy chain (distinct from HLA-A/B/C molecules)
These antibodies are critical for studying T-cell development and immune responses.
Key findings from studies of T6-targeting antibodies:
| Antibody Clone | Target Epitope | Molecular Weight (Heavy Chain) | Cross-Reactivity |
|---|---|---|---|
| OKT6 | T6 antigen | 48 kDa | None with murine TL antigens |
| Leu-6 | T6 antigen | 48 kDa | Binds β2-microglobulin |
| C56 | T6 antigen | 48 kDa | Similar to OKT6 |
Specificity: These antibodies recognize a conserved epitope on the T6 heavy chain, with no polymorphism detected across individuals .
Structural Distinction: The T6 light chain (βt) differs from β2-microglobulin in isoelectric point and peptide composition .
Role in Immunity: The T6 antigen is implicated in early T-cell maturation and antigen presentation. Antibodies like OKT6 and Leu-6 are used to identify Langerhans cells and thymic epithelial cells .
Therapeutic Potential: While not directly cited for HST6, monoclonal antibodies targeting similar glycoproteins (e.g., anti-HHV-6B KH-1 and OHV-3) demonstrate neutralizing efficacy against viral infections, suggesting analogous applications for T6-targeting antibodies .
Diagnostic Use: T6 antibodies are employed in flow cytometry to isolate immune cell subsets (e.g., CD1a+ dendritic cells) .
Mechanistic Studies:
HST6 (UniProt Number: P53706) is a protein expressed in fungal species, particularly in Candida albicans strain WO-1 . It belongs to a family of proteins involved in various cellular processes in yeast. The protein is significant for researchers studying fungal biology and host-pathogen interactions. When designing experiments involving HST6, it's important to consider the specific strain of Candida, as protein expression levels and characteristics may vary between different fungal strains.
Currently, polyclonal HST6 antibodies are available for research applications. Specifically, rabbit polyclonal antibodies purified by antigen affinity are documented in the literature . These antibodies are unconjugated and designed for use in techniques including ELISA and Western blot applications. The commercially available antibodies are typically developed using recombinant Candida albicans (strain WO-1) HST6 protein as the immunogen .
For optimal antibody performance and longevity, HST6 antibodies should be stored at -20°C or -80°C . When working with these antibodies, standard antibody handling protocols apply:
Minimize freeze-thaw cycles by preparing working aliquots
Thaw samples on ice or at 4°C
Use sterile technique when handling antibody solutions
Follow manufacturer's recommendations for dilution factors in specific applications
Monitor storage conditions regularly and avoid temperature fluctuations
HST6 antibodies have been validated for ELISA and Western blot (WB) applications . They are particularly useful in research contexts investigating:
Candida albicans protein expression patterns
Host-pathogen interactions involving fungal species
Comparative studies of protein expression across different fungal strains
Investigating cellular responses to antifungal treatments
Characterizing fungal infection mechanisms in various experimental models
Validating antibody specificity is crucial for generating reliable research data. For HST6 antibodies, consider this comprehensive validation approach:
Positive and negative controls: Use the provided antigen (200μg) as a positive control and pre-immune serum (1ml) as a negative control .
Cross-reactivity testing: Test against multiple fungal species to determine specificity beyond Candida albicans.
Knockout/knockdown validation: If possible, use HST6 knockdown or knockout fungal strains to confirm antibody specificity.
Immunoprecipitation followed by mass spectrometry: This can confirm that the antibody is binding to the expected protein target.
Comparative analysis: Run parallel experiments with other antibodies targeting the same protein if available.
Peptide competition assay: Pre-incubate the antibody with purified HST6 protein before application in your assay to demonstrate binding specificity.
HST6 antibodies can facilitate sophisticated analyses of Candida-host interactions through multiple methodological approaches:
Infection models analysis: Use the antibody to track HST6 expression during various stages of infection in cell culture or animal models.
Co-localization studies: Combine HST6 antibody with cellular markers to determine the spatial relationship between fungal proteins and host cellular components using confocal microscopy.
Temporal expression analysis: Apply the antibody in time-course experiments to monitor changes in HST6 expression during infection progression.
Interaction with immune cells: Study how HST6 expression changes when Candida interacts with different immune cell populations, particularly relevant as research has shown that Candida albicans can stimulate differentiation of hematopoietic stem and progenitor cells (HSPCs) in a TLR2-dependent manner .
Ex vivo tissue analysis: Apply the antibody to infected tissue samples to identify patterns of protein expression in the context of the host environment.
While the currently documented applications for HST6 antibodies are ELISA and Western blot , researchers adapting these antibodies for immunohistochemistry should consider:
Fixation optimization: Test multiple fixation methods (paraformaldehyde, methanol, acetone) to determine optimal antigen preservation.
Antigen retrieval: Systematically evaluate different retrieval methods (heat-induced, enzymatic) to maximize epitope accessibility.
Blocking optimization: Test various blocking reagents to minimize background while preserving specific signal.
Dilution series: Perform careful titration experiments to determine optimal antibody concentration.
Detection system selection: Compare chromogenic versus fluorescent detection systems based on your research questions.
Controls: Include appropriate positive controls (known HST6-expressing Candida samples), negative controls (samples without the target), and technical controls (primary antibody omission).
HST6 antibodies can provide valuable insights into antifungal resistance through several methodological approaches:
Protein expression monitoring: Quantify changes in HST6 expression in resistant versus susceptible strains using Western blot analysis.
Subcellular localization studies: Determine if HST6 localization changes in response to antifungal exposure using fractionation followed by immunoblotting.
Proteomics integration: Use HST6 antibodies for immunoprecipitation followed by mass spectrometry to identify interaction partners that may change during resistance development.
Time-course analysis: Monitor dynamic changes in HST6 expression during acquisition of resistance using the antibody in Western blot applications.
Comparative analysis across strains: Apply the antibody to analyze HST6 expression across clinical isolates with varying resistance profiles.
For Western blot applications with HST6 antibodies, consider the following protocol optimizations:
Sample preparation: For fungal samples, use glass bead disruption in the presence of protease inhibitors to ensure complete protein extraction.
Protein loading: Load 20-50μg of total protein per lane, with precise quantification using Bradford or BCA assays.
Gel percentage: Use 10-12% SDS-PAGE gels for optimal resolution of the HST6 protein.
Transfer conditions: Optimize transfer conditions based on protein size, typically using semi-dry transfer at 15V for 30 minutes or wet transfer at 100V for 1 hour.
Blocking: Use 5% non-fat dry milk in TBST for 1 hour at room temperature.
Primary antibody: Dilute HST6 antibody according to manufacturer specifications, typically 1:1000 to 1:2000, and incubate overnight at 4°C.
Secondary antibody: Use anti-rabbit HRP-conjugated secondary antibody at 1:5000 dilution for 1 hour at room temperature.
Detection: Apply enhanced chemiluminescence (ECL) substrates and image using a digital imaging system.
To investigate evolutionary conservation using HST6 antibodies:
Comparative Western blot: Apply the antibody against protein extracts from multiple fungal species to assess cross-reactivity.
Epitope mapping: Determine the specific epitope(s) recognized by the antibody and analyze sequence conservation of these regions across species.
Functional domain analysis: Use the antibody to determine if conserved domains show differential expression or modification patterns across species.
Phylogenetic correlation: Correlate antibody reactivity patterns with established phylogenetic relationships between fungal species.
Structural homology investigation: Combine antibody-based detection with structural prediction tools to analyze functional conservation.
| Parameter | Specification |
|---|---|
| Article Number | CSB-PA347428XA01CZE-2 |
| Clone Type | Polyclonal |
| Host | Rabbit |
| Immunogen | Recombinant Candida albicans (strain WO-1) HST6 protein |
| Applications | ELISA, Western blot |
| Species Reactivity | Fungi, yeast |
| Isotype | IgG |
| Purification Method | Antigen Affinity |
| Storage Conditions | -20°C or -80°C |
| UniProt Number | P53706 |
| Size | 2mg |
| Components | 200μg antigens (positive control), 1ml pre-immune serum (negative control), Purified rabbit polyclonal antibodies |
Table 1: Technical specifications of commercially available HST6 antibody .
Researchers may encounter several challenges when working with HST6 antibodies:
High background in Western blots
Solution: Optimize blocking conditions (increase blocking time, try different blocking agents), increase washing duration and frequency, and reduce primary antibody concentration.
Weak or absent signal
Solution: Ensure adequate protein loading, optimize protein extraction from fungal cells (consider different lysis buffers), increase antibody concentration, extend incubation time, or enhance detection sensitivity.
Non-specific bands
Solution: Increase antibody specificity through more stringent washing, adjust antibody dilution, or perform peptide competition assays to identify specific bands.
Batch-to-batch variability
Solution: Validate each new antibody lot against a reference sample, maintain consistent experimental conditions, and consider creating a large stock of a validated lot for long-term studies.
Sample degradation
Solution: Use fresh samples when possible, add protease inhibitors during extraction, maintain samples at appropriate temperatures, and minimize freeze-thaw cycles.